Business
Doseology Engages McKinney Regulatory Science Advisors to Advance Innovative Oral Pouch Product Development through Science and Regulatory Expertise
Doseology Sciences Inc. (CSE: MOOD) (PINK: DOSEF) (FSE: VU70) ("Doseology" or the "Company") a leader in biotechnology-driven consumer products, today announced a strategic partnership with McKinney Regulatory Science Advisors ("McKinney"), a premier FDA regulatory consulting firm specializing in nicotine and reduced-risk consumer products, to spearhead its regulatory submission strategy and solidify its commitment to scientific leadership in the oral pouch technology space.
About this update from Doseology Sciences, Inc.
[{"type":"text","content":"KELOWNA, BC, Jan. 12, 2026 /PRNewswire/ -- Doseology Sciences Inc. (CSE: MOOD) (PINK: DOSEF) (FSE: VU70) ("Doseology" or the "Company") a leader in biotechnology-driven consumer products, today announced a strategic partnership with McKinney Regulatory Science Advisors ("McKinney"), a premier FDA regulatory consulting firm specializing in nicotine and reduced-risk consumer products, to spearhead its regulatory submission strategy and solidify its commitment to scientific leadership in the oral pouch technology space.","length":552,"tagName":"p"},{"type":"image","alt":"Doseology Sciences Inc. Logo","displaySize":"","headline":null,"caption":"Doseology Sciences Inc. Logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":209,"url":"https://media.zenfs.com/en/cnwgroup.com/5074e94047bc8f0af85685e5b26bfc79"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/kUX47EfH3IivgeNGTEFKvA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTM2ODtjZj13ZWJw/https://media.zenfs.com/en/cnwgroup.com/5074e94047bc8f0af85685e5b26bfc79","width":400,"height":209}},"href":"https://mma.prnewswire.com/media/2858641/Doseology_Sciences_Inc_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"This collaboration marks a pivotal advancement for Doseology, transitioning the Company towards regulatory execution and commercial readiness. McKinney's comprehensive guidance will encompass formulation strategy, data generation, Pre-market Tobacco Product Application ("PMTA") preparation, and post-market compliance. The aim is to position Doseology as a frontrunner in delivering differentiated, IP and/or trade secret protected oral pouch products to regulated markets with confidence.","length":504,"tagName":"p"},{"type":"text","content":""Doseology is committed to leading with science and innovation in the oral pouch category. Engaging McKinney, a leader in regulatory science, ensures that our product development is not only innovative but also strategically aligned with regulatory expectations," said Tim Corkum, President & COO of Doseology. "This partnership underscores our dedication to building a defensible, regulatory-ready platform that prioritizes dose consistency and consumer safety."","length":487,"tagName":"p"},{"type":"text","content":""At McKin...